Literature DB >> 3921699

Trypanosoma cruzi: biological characterization of clones derived from chronic chagasic patients. II. Quantitative analysis of the intracellular cycle.

J C Engel, P S Doyle, J A Dvorak.   

Abstract

The complete intracellular cycle of five cloned stocks of Trypanosoma cruzi was quantified. Marked but stable interclonal differences were found in the length of the pre-replicative lag period (18.2-34.2 h), amastigote doubling time (8.6-21.5 h), and duration of the complete intracellular cycle (96-215 h). Strong correlations were demonstrated between these characteristics as well as to the growth rate of the epimastigote stage of the same clones grown in liquid medium. These data demonstrate that the marked heterogeneity of the natural population of T. cruzi extends to the intracellular cycle of the parasite and has important implications for our understanding of Chagas' disease.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3921699     DOI: 10.1111/j.1550-7408.1985.tb03017.x

Source DB:  PubMed          Journal:  J Protozool        ISSN: 0022-3921


  13 in total

1.  Two approaches to discovering and developing new drugs for Chagas disease.

Authors:  J H McKerrow; P S Doyle; J C Engel; L M Podust; S A Robertson; R Ferreira; T Saxton; M Arkin; I D Kerr; L S Brinen; C S Craik
Journal:  Mem Inst Oswaldo Cruz       Date:  2009-07       Impact factor: 2.743

2.  Why does GM1 induce a potent beneficial response to experimental Chagas disease?

Authors:  S Cossy Isasi; C A Condat; G J Sibona
Journal:  HFSP J       Date:  2009-01-21

3.  Variation in antigenic determinants specific to the infective stage of Trypanosoma cruzi.

Authors:  R A Wrightsman; W Leon; J E Manning
Journal:  Infect Immun       Date:  1986-08       Impact factor: 3.441

4.  Image-based high-throughput drug screening targeting the intracellular stage of Trypanosoma cruzi, the agent of Chagas' disease.

Authors:  Juan C Engel; Kenny K H Ang; Steven Chen; Michelle R Arkin; James H McKerrow; Patricia S Doyle
Journal:  Antimicrob Agents Chemother       Date:  2010-06-14       Impact factor: 5.191

5.  Characterization and grouping of Trypanosoma cruzi stocks by DNA base-specific fluorochromes and discriminant analysis.

Authors:  H Mühlpfordt; J Berger
Journal:  Parasitol Res       Date:  1990       Impact factor: 2.289

6.  Influence of the long-term Trypanosoma cruzi infection in vertebrate host on the genetic and biological diversity of the parasite.

Authors:  V M Veloso; A J Romanha; M Lana; S M F Murta; C M Carneiro; C F Alves; E C Borges; W L Tafuri; G L L Machado-Coelho; E Chiari; M T Bahia
Journal:  Parasitol Res       Date:  2005-06-07       Impact factor: 2.289

7.  Negative tissue parasitism in mice injected with a noninfective clone of Trypanosoma cruzi.

Authors:  M T Lima; H L Lenzi; C R Gattass
Journal:  Parasitol Res       Date:  1995       Impact factor: 2.289

Review 8.  Enucleated L929 cells support invasion, differentiation, and multiplication of Trypanosoma cruzi parasites.

Authors:  Vanessa C Coimbra; Denise Yamamoto; Ketna G Khusal; Vanessa Diniz Atayde; Maria Cecília Fernandes; Renato A Mortara; Nobuko Yoshida; Maria Julia M Alves; Michel Rabinovitch
Journal:  Infect Immun       Date:  2007-05-14       Impact factor: 3.441

9.  The Trypanosoma cruzi protease cruzain mediates immune evasion.

Authors:  Patricia S Doyle; Yuan M Zhou; Ivy Hsieh; Doron C Greenbaum; James H McKerrow; Juan C Engel
Journal:  PLoS Pathog       Date:  2011-09-01       Impact factor: 6.823

10.  Diverse inhibitor chemotypes targeting Trypanosoma cruzi CYP51.

Authors:  Shamila S Gunatilleke; Claudia M Calvet; Jonathan B Johnston; Chiung-Kuang Chen; Grigori Erenburg; Jiri Gut; Juan C Engel; Kenny K H Ang; Joseph Mulvaney; Steven Chen; Michelle R Arkin; James H McKerrow; Larissa M Podust
Journal:  PLoS Negl Trop Dis       Date:  2012-07-31
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.